Iqbal, Arham, Zaeem Ahmed Abbasi, and Fahad Naeem. 2022. “Benefits of Six Week and Personalized Dosing of Pembrolizumab Considering Ongoing Delta Variant Surge”. Journal of the Pakistan Medical Association 72 (3). https://doi.org/10.47391/JPMA.4660.